Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis

15 June 2020 : Clinical Research

Sikai Nong^1BCD, Xinbin Pan^1BCD, Kaihua Chen^1EF, Ye Li^1CD, Xiaodong Zhu^1AFG*

DOI: 10.12659/MSM.922244

Med Sci Monit 2020; 26:e922244

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Comparison of the different chemotherapy cycles between the 2 groups.

Chemotherapy	Cycle(N)	<6-cycle N(%)	≥6-cycle N(%)	P-value
Palliative				0.421
TPF	≤4	19 (65.5%)	16 (55.2%)
TPF	>4	10 (34.5%)	13 (44.8%)
Concurrent				1.000
DDP	0	20 (69.0%)	21 (72.4%)
	1	2 (6.9%)	2 (6.9%)
	2	3 (10.3%)	2 (6.9%)
	3	4 (13.8%)	4 (13.8%)
TPF – docetaxel, cisplatin and 5-fluorouracil; DDP – cisplatin.

Back to the Article